Royal Bank of Canada’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.57M | Buy |
374,969
+374,234
| +50,916% | +$3.56M | ﹤0.01% | 2600 |
|
|
2025
Q1 | $8K | Sell |
735
-1,382
| -65% | -$15K | ﹤0.01% | 5834 |
|
|
2024
Q4 | $50K | Sell |
2,117
-7,590
| -78% | -$179K | ﹤0.01% | 5205 |
|
|
2024
Q3 | $349K | Buy |
9,707
+1,619
| +20% | +$58.2K | ﹤0.01% | 3961 |
|
|
2024
Q2 | $285K | Buy |
8,088
+3,069
| +61% | +$108K | ﹤0.01% | 4091 |
|
|
2024
Q1 | $143K | Sell |
5,019
-9,415
| -65% | -$268K | ﹤0.01% | 4525 |
|
|
2023
Q4 | $191K | Buy |
14,434
+6,424
| +80% | +$85K | ﹤0.01% | 4620 |
|
|
2023
Q3 | $71K | Buy |
8,010
+2,932
| +58% | +$26K | ﹤0.01% | 5100 |
|
|
2023
Q2 | $57K | Buy |
5,078
+2,140
| +73% | +$24K | ﹤0.01% | 5263 |
|
|
2023
Q1 | $33K | Sell |
2,938
-1,796
| -38% | -$20.2K | ﹤0.01% | 5445 |
|
|
2022
Q4 | $55K | Buy |
4,734
+3,185
| +206% | +$37K | ﹤0.01% | 5355 |
|
|
2022
Q3 | $20K | Buy |
1,549
+208
| +16% | +$2.69K | ﹤0.01% | 5643 |
|
|
2022
Q2 | $9K | Sell |
1,341
-1,668
| -55% | -$11.2K | ﹤0.01% | 5953 |
|
|
2022
Q1 | $29K | Sell |
3,009
-4,429
| -60% | -$42.7K | ﹤0.01% | 5913 |
|
|
2021
Q4 | $88K | Buy |
7,438
+2,492
| +50% | +$29.5K | ﹤0.01% | 5494 |
|
|
2021
Q3 | $81K | Buy |
4,946
+2,886
| +140% | +$47.3K | ﹤0.01% | 5339 |
|
|
2021
Q2 | $43K | Buy |
2,060
+518
| +34% | +$10.8K | ﹤0.01% | 5639 |
|
|
2021
Q1 | $24K | Buy |
1,542
+886
| +135% | +$13.8K | ﹤0.01% | 5824 |
|
|
2020
Q4 | $14K | Buy |
+656
| New | +$14K | ﹤0.01% | 5667 |
|